Maha Radhakrishnan, M.D.

Maha Radhakrishnan, M.D.

DirectoratAlto Neuroscience· In proxies 2024–2025

Maha Radhakrishnan, M.D. sits on 1 public board.

Experience

  1. Alto NeurosciencePublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  2. Minovia TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?